Kurian Joseph

Contact Overview Publications

Contact

Faculty of Medicine & Dentistry - Oncology Dept

Email: kjoseph@ualberta.ca
Phone: (780) 432-8755
Address: Cross Cancer Institute
11560 University Avenue

Edmonton AB

T6G 1Z2

Overview

Area of Study / Keywords

About

Clinical interests:
Gastrointestinal cancers, breast cancer and cutaneous malignancies

Research

Radiation related side effects
Image guided radiotherapy
Re-irradiation

Featured Publications

Metastatic melanoma refractory to immune-checkpoint inhibitors: Can radiotherapy improve the immunotherapy response?

CARO Virtual Meeting. 2022 October;

Leptomeningeal Melanoma Arising in a Patient With Congenital Melanocytic Nevi

Leptomeningeal Melanoma Arising in a Patient With Congenital Melanocytic Nevi. Poster presentation Congress of the International Pediatric Radiation Oncology Society, Essen, Germany. 2022 June;

Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial

Abraham A., Sanghera K.P., Gheisari F., Koumna S., Riauka T., Ghosh S., Warkentin H., Gabos Z., Chafe S., Tankel K., Huang F., Sabri S., Paterson D.I., Abdulkarim B., Joseph K.

International Journal of Radiation Oncology Biology Physics. 2022 May; 113 (1):125-134 10.1016/j.ijrobp.2022.01.020

More is not better when it comes to treating rectal cancer with multimodal chemoradiation beyond the standard radiation dose of 5040 CGy

Abraham A.G., Joseph K., Ghosh S., Yun J., Warkentin B.J., Thai J.A.J., Cheung W.Y., Xu Y., Nijjar T.S., Severin D.M., Tankel K., Fairchild A.M., Usmani N.

Diseases of the Colon and Rectum. 2022 May; 65 (5):692-701 10.1097/DCR.0000000000001986

Patterns of failure in anal cancer after IMRT and chemotherapy: Impact of 1 vs 2 doses of Mitomycin

ESTRO 2022. 2022 May;

PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma

Joseph K., Walker J., Raziee H., Faruqi S., Smylie M.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY. 2022 May; 26 (3):243-248 10.1177/12034754211064273

Are two too many when it comes to the treatment of anal canal cancer with concurrent radiation and Mitomycin C?

2022 ASCO Gastrointestinal Cancers Symposium,. 2022 January;

Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?

Abraham A.G., Joseph K., Spratlin J.L., Zebak S., Alba V., Iafolla M., Ghosh S., Abdelaziz Z., Lui A., Paulson K., Bedard E., Chua N., Tankel K., Koski S., Scarfe A., Severin D., Zhu X., King K., Easaw J.C., Mulder K.E.

Clinical Oncology. 2022 January; 10.1016/j.clon.2022.05.011

Patterns and predictors of relapse in Merkel cell carcinoma: Results from a population-based study

Joseph K., Wong J., Abraham A., Zebak J., Patel A., Jones Thachuthara A., Iqbal U., Pham T.M., Menon A., Ghosh S., Warkentin H., Walker J., Jha N., Faruqi S., Salopek T.G., Smylie M.

Radiotherapy and Oncology. 2022 January; 166 10.1016/j.radonc.2021.11.015

The use of proton pump inhibitors does not adversely influence pathological and clinical outcomes when used with capecitabine in the neo-adjuvant chemo-radiation treatment of locally advanced rectal cancer.

CARO Virtual Meeting. 2021 October;

Tumor volume predicts for pathological complete response in rectal cancer patients treated with neoadjuvant chemoradiation

CARO Virtual Meeting. 2021 October;

Response and toxicity patterns seen in patients treated with radiotherapy in the UNSCARRED (unresectable squamous cell carcinoma treated with Avelumab and radical radiotherapy) study.

CARO Virtual Meeting. 2021 October;

Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients

Yang R., Younis M., Joseph K., Ghosh S., Nijjar T., Severin D., Tankel K., Tamhane Y., Fairchild A., Spratlin J., Mulder K., Usmani N.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021 October; 27 (7):1596-1603 10.1177/1078155220962192

Five year survival, toxicity and patient-reported quality of life after intensity modulated radiation therapy (IMRT) base concurrent chemoradiotherapy for locally advanced anal cancer.

CARO Virtual Meeting. 2021 October;

Concomitant Use of Proton Pump Inhibitors with Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?

Menon A., Abraham A.G., Mahfouz M., Thachuthara J.J., Usmani N., Warkentin H., Ghosh S., Nijjar T., Severin D., Tankel K., Paulson K., Mulder K., Roa W., Joseph K.

American Journal of Clinical Oncology: Cancer Clinical Trials. 2021 September; 44 (9):487-494 10.1097/COC.0000000000000850

Patterns and predictors of relapse in Merkel Cell carcinoma: Results from a population based study.

ESTRO Annual Meeting. 2021 August;

More Is Not Better When It Comes to Treating Rectal Cancer With Multimodal Chemoradiation Beyond the Standard Radiation Dose of 5040 cGy

Aswin George Abraham , Kurian Joseph, Sunita Ghosh, Jihyun Yun, Brad Warkentin, JoAnn Thai, Winson Cheung, Yuan Xu, Tirath Nijjar, Diane Severin, Keith Tankel, Alysa Fairchild, Nawaid Usmani

Diseases of the Colon and Rectum. 2021 June; 10.1097/DCR.0000000000001986

Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial

Morielli A.R., Usmani N., Boulé N.G., Severin D., Tankel K., Joseph K., Nijjar T., Fairchild A., Courneya K.S.

Clinical Colorectal Cancer. 2021 May; 20 (3):216-226 10.1016/j.clcc.2021.05.004

Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study

Joseph K., Zebak S., Alba V., Mah K., Au C., Vos L., Ghosh S., Abraham A., Chafe S., Wiebe E., Liu H.W., Chambers C., Gabos Z., Tankel K., Lupichuk S., King K.

Radiotherapy and Oncology. 2021 January; 154 10.1016/j.radonc.2020.09.017

Dosimetric Parameters Predicting Late Small Bowel Toxicity in Patients With Rectal Cancer Receiving Neoadjuvant Chemoradiation

Abraham A.G., Usmani N., Warkentin B., Thai J.A., Yun J., Ghosh S., Cheung W., Xu Y., Nijjar T., Severin D., Tankel K., Fairchild A., Joseph K.

Practical Radiation Oncology. 2021 January; 11 (1):e70-e79 10.1016/j.prro.2020.07.004

Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial

Morielli A.R., Boulé N.G., Usmani N., Tankel K., Joseph K., Severin D., Fairchild A., Nijjar T., Courneya K.S.

Journal of Cancer Survivorship. 2021 January; 10.1007/s11764-021-01149-w

Skin toxicity in early breast cancer patients treated with field-in-field breast intensity-modulated radiotherapy versus helical inverse breast intensity modulated radiotherapy: Results of a Phase III radmonized controlled trial

Joseph K, Vos LJ, Gabos Z, Pervez N, Chafe S, Tankel K, Warkentin H, Ghosh S, Amanie J, Powell K, Polkosnik LA, Horsman S, MacKenzie M, Sabri S, Parliament MB, Mackey J, Abdulkarim B

CLINICAL ONCOLOGY. 2021 January; doi.org/10.1016

Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial

Joseph K., Vos L.J., Gabos Z., Pervez N., Chafe S., Tankel K., Warkentin H., Ghosh S., Amanie J., Powell K., Polkosnik L.A., Horsman S., MacKenzie M., Sabri S., Parliament M.B., Mackey J., Abdulkarim B.

Clinical Oncology. 2021 January; 33 (1):30-39 10.1016/j.clon.2020.07.005

Management of Stage IV rectal cancers with oligometastatic disease at presentation: A single institution experience

International Journal Radiation Oncology Biology Physics. 2020 November;

Optimal FDG-PET parameters for detecting inguinal nodeal metastasis in anal squamous cell cancer

International Journal Radiation Oncology Biology Physics. 2020 November;